DiaMedica Therapeutics DMAC
NASDAQ DMAC
$8.35 +0.08 (+0.97%)
At close: Oct 1, 2026 · 4:00 PM EDT

DiaMedica Therapeutics (DMAC) Depreciation & Amortization (CF) (2018 - 2026)

Updated

DiaMedica Therapeutics (DMAC) recorded Depreciation & Amortization (CF) of $12,000 in Q2 2026, up 300.0% from $3,000 a year earlier and up 9.1% from the prior quarter.

Analysis

DiaMedica Therapeutics (DMAC) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends

On a TTM basis, DiaMedica Therapeutics' Depreciation & Amortization (CF) came in at $52,000 as of Jun 30, 2026, up 48.6% year-over-year; for FY2025, it was $43,000, up 10.3% from FY2024.

  • Annual Depreciation & Amortization (CF) has increased for five straight years, with a five-year compound annual growth rate of 15.4% (FY2020 to FY2025).
  • Across earlier years, Depreciation & Amortization (CF) came in at $39,000 in FY2024 (+30.0%), $30,000 in FY2023 (+20.0%), $25,000 in FY2022 (+4.2%) and $24,000 in FY2021 (+14.3%).
  • Quarterly Depreciation & Amortization (CF) has ranged from $3,000 in Q2 2025 to $18,000 in Q3 2025 over the past five years.
  • On a year-over-year basis, Depreciation & Amortization (CF) rose in five of the last eight quarters, with growth averaging 51.3%.
  • Peak year-over-year performance for Depreciation & Amortization (CF) in the last five years was growth of 300.0% in Q2 2026, against a decline of 70.0% in Q2 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $11,000 (Q1 2026), $11,000 (Q4 2025) and $18,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 DiaMedica Therapeutics 445.97 Mn 445.97 Mn - 12,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12,000.00
Mar 31, 2026 11,000.00
Dec 31, 2025 11,000.00
Sep 30, 2025 18,000.00
Jun 30, 2025 3,000.00
Mar 31, 2025 11,000.00
Dec 31, 2024 11,000.00
Sep 30, 2024 10,000.00
Jun 30, 2024 10,000.00
Mar 31, 2024 8,000.00
Dec 31, 2023 8,000.00
Sep 30, 2023 8,000.00
Jun 30, 2023 7,000.00
Mar 31, 2023 7,000.00
Dec 31, 2022 6,000.00
Sep 30, 2022 7,000.00
Jun 30, 2022 6,000.00
Mar 31, 2022 6,000.00
Dec 31, 2021 6,000.00
Sep 30, 2021 6,000.00
API Access

DiaMedica Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=DMAC&period=max&api_key=YOUR_API_KEY